Education
Ondokuz Mayıs University Faculty of Medicine (1991)
KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)
Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)
Read more
Education
Ondokuz Mayıs University Faculty of Medicine (1991)
KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)
Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)
Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)
Specializations
Cancer Surgery
Pancreatic Surgery
Bile Duct Surgery
Bariatric Metabolic Surgery
Oncological Surgery
Breast Surgery
Gastric cancer
Colon cancer
Thyroid Cancer
Obesity Surgery
Diabetes Surgeries
Read more
Specializations
Cancer Surgery
Pancreatic Surgery
Bile Duct Surgery
Bariatric Metabolic Surgery
Oncological Surgery
Breast Surgery
Gastric cancer
Colon cancer
Thyroid Cancer
Obesity Surgery
Diabetes Surgeries
Specializations
Oncological Surgery (Cancer Surgery)
Breast Diseases Surgery
Gallbladder and biliary tract diseases surgery
Thyroid – Parathyroid Surgery
Inguinal and Abdominal Wall Hernia, Stomach Hernia Surgery
Closed (Laparoscopic) Hernia Surgery
Endoscopy Applications
Treatment of Gastrointestinal System Diseases
Read more
Specializations
Oncological Surgery (Cancer Surgery)
Breast Diseases Surgery
Gallbladder and biliary tract diseases surgery
Thyroid – Parathyroid Surgery
Inguinal and Abdominal Wall Hernia, Stomach Hernia Surgery
Closed (Laparoscopic) Hernia Surgery
Endoscopy Applications
Treatment of Gastrointestinal System Diseases
Head of Teaching at the Puerto Vallarta Regional Hospital
2020-2023
Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020
General practitioner in private medical office
2015-2022
Doctor in charge of weight control clinic
2013-2014
Medical assistant in dermatology clinic
2008-2013
Medical Assistant in Dermatological procedures.
Medical Assistant in minimally invasive surgical procedures
Operation of fractional laser machine - IPIXEL-ER and
facial rejuvenation with IPL.
Experience in laser hair removal with Intense Pulsed Light and
radiofrequency
Experience with ultrasonic cavitation
Experience with ultraviolet (UV) light phototherapy machine for the
treatment of psoriasis and vitiligo.
Experience assisting in Botox and Fillers procedures.
Biomagnet certified by the Higher Institute of Biomagnetism
doctor ISAAC GOIZ DURAN
Experience in clinical records
Training in continuing education and professional development of teachers
Read moreHead of Teaching at the Puerto Vallarta Regional Hospital
2020-2023
Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020
General practitioner in private medical office
2015-2022
Doctor in charge of weight control clinic
2013-2014
Medical assistant in dermatology clinic
2008-2013
Medical Assistant in Dermatological procedures.
Medical Assistant in minimally invasive surgical procedures
Operation of fractional laser machine - IPIXEL-ER and
facial rejuvenation with IPL.
Experience in laser hair removal with Intense Pulsed Light and
radiofrequency
Experience with ultrasonic cavitation
Experience with ultraviolet (UV) light phototherapy machine for the
treatment of psoriasis and vitiligo.
Experience assisting in Botox and Fillers procedures.
Biomagnet certified by the Higher Institute of Biomagnetism
doctor ISAAC GOIZ DURAN
Experience in clinical records
Training in continuing education and professional development of teachers
Personal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Read morePersonal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Read more
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
Dr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.
She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).
In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.
Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.
Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.
In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.
Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.
She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.
She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).
Read moreDr. Sullivan graduated in Medicine and Surgery from the National University of Rosario in 2005, specializing in Medical Oncology through the MIR at the Santa Creu i Sant Pau Hospital (HSCiSP, 2012) in Barcelona.
She received a post-MIR scholarship from the Ministry of Interior from HSPiSP (2012) and then a pre-doctoral scholarship from ISCiii (Rio Hortega – 2013-2015).
In 2014, he moved to Paris where he obtained a DUERTECC diploma at the Gustave Roussy University Hospital (Villejuif), followed by an ESMO scholarship (Georges Mathé Translator Scholarship), which he received in 2016.
Since January 2017, he has been working on the staff of the Medical Oncology Department of the HSCiSP. In the same year, he obtained his PhD from the Autonomous University of Barcelona.
Since 2015, he has been a member of the Board of Directors of the Spanish Lung Cancer Group (GECP). And since 2022, he has been the coordinator of the HSCiSP Committee on Neuroendocrine Tumors.
In November 2021, she joined the IOR Medical Oncology Service and is actively involved in various research projects in the Pangea Lab under the supervision of Dr. Molina.
Dr. Sullivan is involved in several clinical trials in lung cancer and neuroendocrine tumors, many of which have been presented at various international scientific meetings.
She has participated in national and international conferences and is an author and co-author of research articles published in influential journals.
She is currently a member of the Spanish Society of Medical Oncology (SEOM), GECP, European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Group of Neuroendocrine and Endocrine Tumors (GETNE).
| Doctor's visit | price on request |
| Stomach cancer surgery | $26973 - $37763 |
Prof. Dr. med. Ulrich Graven
Head of the Clinic of Hematology, Oncology and Gastroenterology
Head of a certified oncology center
Head of Clinical Research Department
Specialization:
Hematology, including stem cell transplantation
Abdominal oncology, especially colorectal and pancreatic cancer therapy
Metastasis therapy, including the use of off-label drugs
Membership in professional societies:
Professional Union of German Therapists
German Society for Internal Medicine
German Cancer Society
Abdominal Oncology Working Group
German Society of Hematology and Oncology
German Working Group on Bone Marrow and Hematopoietic Cell Transplantation
German Society for Digestive and Metabolic Diseases
European Society for Medical Oncology
American Society of Clinical Oncology
American Association for Cancer Research
Activities in professional communities:
German Cancer Society:
Since 2013, speaker of the commission for certification of oncology centers
Since November 2007, member of the board
Since September 2022, Speaker of the Section of National Societies on Cancer Control
Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.
Chairman of the Oncology Society of North Rhine-Westphalia.
Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.
Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.
Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.
Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.
Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.
Member of the committee for the development of clinical guidelines for colorectal cancer.
Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.
Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.
Read moreProf. Dr. med. Ulrich Graven
Head of the Clinic of Hematology, Oncology and Gastroenterology
Head of a certified oncology center
Head of Clinical Research Department
Specialization:
Hematology, including stem cell transplantation
Abdominal oncology, especially colorectal and pancreatic cancer therapy
Metastasis therapy, including the use of off-label drugs
Membership in professional societies:
Professional Union of German Therapists
German Society for Internal Medicine
German Cancer Society
Abdominal Oncology Working Group
German Society of Hematology and Oncology
German Working Group on Bone Marrow and Hematopoietic Cell Transplantation
German Society for Digestive and Metabolic Diseases
European Society for Medical Oncology
American Society of Clinical Oncology
American Association for Cancer Research
Activities in professional communities:
German Cancer Society:
Since 2013, speaker of the commission for certification of oncology centers
Since November 2007, member of the board
Since September 2022, Speaker of the Section of National Societies on Cancer Control
Chairman of the working group on abdominal oncology of the German Cancer Society, drafting clinical guidelines for the treatment of colorectal and pancreatic cancer.
Chairman of the Oncology Society of North Rhine-Westphalia.
Member of the Colorectal Cancer Clinical Guidelines Working Group, European Society for Medical Oncology.
Member of the Scientific Council, National Cancer Registry at the Robert Koch Institute.
Chairman of the Regional Cancer Registry of the State of North Rhine-Westphalia.
Leading expert for clinical research, German Research Foundation and Federal Ministry of Research and Technology.
Member of the Commission on the Use of Medicines for Therapy "Off-Label", Federal Institute of Medicines and Medical Devices.
Member of the committee for the development of clinical guidelines for colorectal cancer.
Member of the commission on the development of approaches to metastasis and the use of palliative therapy in clinical guidelines for colorectal cancer.
Reviewer of scientific journals such as Journal of Cancer Research and Clinical Oncology, Tumor Diagnostik und Therapie, Der Schmerz, BMC Pharmacology, Onkologie, Strahlentherapie und Onkologie, International Journal of Colorectal Disease, Annuals of Oncology, European Journal of Cancer.
Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr 18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery. • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations
Read moreActivities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr 18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery. • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations
Prof. Dr. Ümmügül Üyetürk completed her undergraduate and graduate education at Uludağ University Faculty of Medicine between 1988-1994. She specialized in Internal Medicine at Istanbul Training and Research Hospital from 1998 to 2003. Between 2008-2011, she received her subspecialty training in Medical Oncology at Ankara Oncology Training and Research Hospital.
After serving as the deputy chief physician at Suluova State Hospital, she established the Internal Medicine Department and Medical Oncology Science Branch at Bolu Abant İzzet Baysal University between 2011-2020, where she served as the head of the science branch. During this time, she educated resident doctors and students. Üyetürk, who received the title of Associate Professor in 2014, spent 6 months in Canada/Toronto in 2019. In 2020, she was awarded the title of Professor at Abant İzzet Baysal University.
Üyetürk has published over 60 articles in international peer-reviewed journals and has more than 20 scientific works published in national peer-reviewed journals. She also has over 100 presentations that have been delivered at international and national scientific meetings and published in proceedings books. In addition to her membership in the European Society for Medical Oncology, she has memberships in medical oncology associations within the country. She has received more than 10 awards given to her at universities and congresses.
Prof. Dr. Ümmügül Üyetürk completed her undergraduate and graduate education at Uludağ University Faculty of Medicine between 1988-1994. She specialized in Internal Medicine at Istanbul Training and Research Hospital from 1998 to 2003. Between 2008-2011, she received her subspecialty training in Medical Oncology at Ankara Oncology Training and Research Hospital.
After serving as the deputy chief physician at Suluova State Hospital, she established the Internal Medicine Department and Medical Oncology Science Branch at Bolu Abant İzzet Baysal University between 2011-2020, where she served as the head of the science branch. During this time, she educated resident doctors and students. Üyetürk, who received the title of Associate Professor in 2014, spent 6 months in Canada/Toronto in 2019. In 2020, she was awarded the title of Professor at Abant İzzet Baysal University.
Üyetürk has published over 60 articles in international peer-reviewed journals and has more than 20 scientific works published in national peer-reviewed journals. She also has over 100 presentations that have been delivered at international and national scientific meetings and published in proceedings books. In addition to her membership in the European Society for Medical Oncology, she has memberships in medical oncology associations within the country. She has received more than 10 awards given to her at universities and congresses.
| Doctor's visit | price on request |
| Stomach cancer surgery | $13000 - $15000 |
Born in 1978, Specialist Dr. Mustafa Solak graduated from Hacettepe University Faculty of Medicine. He completed his residency at Istanbul Şişli Etfal Training and Research Hospital and received his Sub-specialty from Hacettepe University Cancer Institute.
He has numerous cases related to Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head and Neck Cancers, and Gastrointestinal System Cancers.
Born in 1978, Specialist Dr. Mustafa Solak graduated from Hacettepe University Faculty of Medicine. He completed his residency at Istanbul Şişli Etfal Training and Research Hospital and received his Sub-specialty from Hacettepe University Cancer Institute.
He has numerous cases related to Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head and Neck Cancers, and Gastrointestinal System Cancers.